iv class="t m0 x1d h15 yf8 ff5 fs0 fc0 sc0 ls0 ws0">mology, Vol. 113, No. 9, 1995, pp. 1200-1202.
[38] G. R. Beauchamp and M. M. Parks, “Filtering Surgery in
Children: Barriers to Success,” Ophthalmology, Vol. 86,
No. 1, 1979, pp. 170-180.
[39] A. K. Mandal, D. S. Walton, T. John, et al., “Mitomycin
C Augmented Trabeculectomy in Refactory Congenital
Glaucoma,” Ophthalmology, Vol. 104, No. 6, 1997, pp.
[40] R. Susanna, E. W. Oltrogge, J. C. E. Carani, et al., “Mi-
tomycin as Adjunct Chemotherapy with Trabeculectomy
in Congenital and Developmental Glaucomas,” Journal of
Glaucoma, Vol. 4, No. 3, 1995, pp. 151-157.
[41] S. Waheed, D. C. Ritterband and D. S. Greenfield, “Bleb-
Related Ocular Infection in Children after Trabeculec-
tomy with Mitomycin C,” Ophthalmology, Vol. 104, No.
12, 1997, pp. 2117-2120.
[42] M. Zalish, H. Leiba and M. Oliver, “Subconjunctival
Injection of 5-Fluorouracil Following Trabeculectomy for
Congenital and Infantile Glaucoma,” Ophthalmic Surgery,
Vol. 23, No. 3, 1992, pp. 203-205.
[43] M. Akimato, H. Tamihara, A. Negi and M. Nagata, “Sur-
gical Results of Trabeculotomy ab Externo for Develop-
mental Glaucoma,” Archives of Ophthalmology, Vol. 112,
No. 12, 1994, pp. 1540-1544.
[44] A. K. Mandal and D. Chakrabarti, “Update on Congenital
Glaucoma,” Indian Journal of Ophthalmology, Vol. 59,
No. 7, 2011, pp. 148-157.